While the percentage of CD62L expressing classical and intermediate monocytes was enhanced in stroke patients only (Figures 5D–F), CD62L percentage and MFI remained unaltered in seizure patients (Figures 5A–C). The gene discussed is SELL; the disease is Stroke.